...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Arvinas /ARVN dBET vs iBET

Bear

Thank you so very much !

Your evaluation helps s great dealĀ and you are very kind to take the time for a detailed narrative

I find the market valuation of ARVN a good proxy for Zeniths near term in addition ????

Share
New Message
Please login to post a reply